Peritonsillar abscess medical therapy: Difference between revisions
Prince Djan (talk | contribs) |
m (Bot: Removing from Primary care) |
||
| (2 intermediate revisions by 2 users not shown) | |||
| Line 5: | Line 5: | ||
==Overview== | ==Overview== | ||
Parenteral therapy is the preferred first line route of administration until the [[temperature]] of the patient has settled and clinically improved and then switched to oral therapy to complete a 14-day course.<ref name="pmid7782170">{{cite journal| author=Apostolopoulos NJ, Nikolopoulos TP, Bairamis TN| title=Peritonsillar abscess in children. Is incision and drainage an effective management? | journal=Int J Pediatr Otorhinolaryngol | year= 1995 | volume= 31 | issue= 2-3 | pages= 129-35 | pmid=7782170 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=7782170 }} </ref> The preferred emperic therapy is [[ampicillin-sulbactam]] with [[clindamycin]] alternative agent. For resistant [[gram-positive cocci]] infections intravenous [[vancomycin]] or [[linezolid]] is added to the above emperic therapy.<ref name="abc">Principles and Practice of Pediatric Infectious Diseases, 4th ed, Long SS, Pickering LK, Prober CG (Eds), Elsevier Saunders, New York 2012. p.205.</ref> | Medical therapy is the first liine treatment modality for peritonsillar abscess. Parenteral therapy is the preferred first line route of administration until the [[temperature]] of the patient has settled and clinically improved and then switched to oral therapy to complete a 14-day course.<ref name="pmid7782170">{{cite journal| author=Apostolopoulos NJ, Nikolopoulos TP, Bairamis TN| title=Peritonsillar abscess in children. Is incision and drainage an effective management? | journal=Int J Pediatr Otorhinolaryngol | year= 1995 | volume= 31 | issue= 2-3 | pages= 129-35 | pmid=7782170 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=7782170 }} </ref> The preferred emperic therapy is [[ampicillin-sulbactam]] with [[clindamycin]] as alternative agent. For resistant [[gram-positive cocci]] infections [[intravenous]] [[vancomycin]] or [[linezolid]] is added to the above emperic therapy.<ref name="abc">Principles and Practice of Pediatric Infectious Diseases, 4th ed, Long SS, Pickering LK, Prober CG (Eds), Elsevier Saunders, New York 2012. p.205.</ref> | ||
==Medical therapy== | ==Medical therapy== | ||
Parenteral therapy is the preferred first line route of administration until the temperature of the patient has settled and clinically improved and then switched to oral therapy to complete a 14-day course.<ref name="pmid7782170">{{cite journal| author=Apostolopoulos NJ, Nikolopoulos TP, Bairamis TN| title=Peritonsillar abscess in children. Is incision and drainage an effective management? | journal=Int J Pediatr Otorhinolaryngol | year= 1995 | volume= 31 | issue= 2-3 | pages= 129-35 | pmid=7782170 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=7782170 }} </ref> | Medical therapy is the first liine treatment modality for peritonsillar abscess. | ||
Parenteral therapy is the preferred first line route of administration until the [[temperature]] of the patient has settled and clinically improved and then switched to oral therapy to complete a 14-day course.<ref name="pmid7782170">{{cite journal| author=Apostolopoulos NJ, Nikolopoulos TP, Bairamis TN| title=Peritonsillar abscess in children. Is incision and drainage an effective management? | journal=Int J Pediatr Otorhinolaryngol | year= 1995 | volume= 31 | issue= 2-3 | pages= 129-35 | pmid=7782170 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=7782170 }} </ref> | |||
====Antimicrobial Regimen==== | ====Antimicrobial Regimen==== | ||
| Line 40: | Line 42: | ||
{{WH}} | {{WH}} | ||
{{WS}} | {{WS}} | ||
[[Category:Emergency mdicine]] | |||
[[Category:Disease]] | |||
[[Category:Up-To-Date]] | |||
[[Category:Infectious disease]] | |||
[[Category:Otolaryngology]] | |||
[[Category:Pediatrics]] | |||
[[Category:Surgery]] | |||
Latest revision as of 23:40, 29 July 2020
|
Peritonsillar abscess Microchapters |
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Peritonsillar abscess medical therapy On the Web |
|
American Roentgen Ray Society Images of Peritonsillar abscess medical therapy |
|
Risk calculators and risk factors for Peritonsillar abscess medical therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Prince Tano Djan, BSc, MBChB [2]
Overview
Medical therapy is the first liine treatment modality for peritonsillar abscess. Parenteral therapy is the preferred first line route of administration until the temperature of the patient has settled and clinically improved and then switched to oral therapy to complete a 14-day course.[1] The preferred emperic therapy is ampicillin-sulbactam with clindamycin as alternative agent. For resistant gram-positive cocci infections intravenous vancomycin or linezolid is added to the above emperic therapy.[2]
Medical therapy
Medical therapy is the first liine treatment modality for peritonsillar abscess.
Parenteral therapy is the preferred first line route of administration until the temperature of the patient has settled and clinically improved and then switched to oral therapy to complete a 14-day course.[1]
Antimicrobial Regimen
Below are the emperic antimicrobial regimen available in treating peritonsillar abscess.[2]
- Preferred regimen in adults: Ampicillin-sulbactam 3 g IV 6h
- Preferred regimen in children: Ampicillin-sulbactam 50 mg/kg per dose [maximum single dose 3 g] IV 6h
- Alternative regimen in adults: Clindamycin 600mg IV 6-8h
- Alternative regimen in children: Clindamycin 13 mg/kg per dose [maximum single dose 900 mg] IV 8h
The above alternative therapy are employed in the following situations:
- Patients not improving on Ampicillin-sulbactam or Clindamycin
- Severe infection presenting with;
- Toxic appearance,
- Temperature >39°C,
- Drooling, and/or respiratory distress)
Pathogen-directed antimicrobial therapy
- Resistant Gram-positive cocci
For resistant gram-positive cocci infections intravenous Vancomycin or linezolid is added to the above emperic therapy.
References
- ↑ 1.0 1.1 Apostolopoulos NJ, Nikolopoulos TP, Bairamis TN (1995). "Peritonsillar abscess in children. Is incision and drainage an effective management?". Int J Pediatr Otorhinolaryngol. 31 (2–3): 129–35. PMID 7782170.
- ↑ 2.0 2.1 Principles and Practice of Pediatric Infectious Diseases, 4th ed, Long SS, Pickering LK, Prober CG (Eds), Elsevier Saunders, New York 2012. p.205.